Article Details
Retrieved on: 2024-03-11 20:32:06
Tags for this article:
Click the tags to see associated articles and topics
Summary
RedHill Biopharma Ltd.'s new patent for Talicia, targeting H. pylori infection, showcases biopharma's role in developing treatments for infectious causes of cancer using unique drug combinations like omeprazole/amoxicillin/rifabutin.
Article found on: www.rttnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here